Purchase Order 75N98026P00639
Award Date 7/19/26
Potential Completion Date 7/18/27
Potential Value $23K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Nexus Group, LLC, an SBA-certified 8(a) small business, for a one-year maintenance agreement on a Bond RXM Autostainer with a ceiling value of $17,880.00, effective June 28, 2026 through June 27, 2027. Work is performed at the NCI facility in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,671 purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a service agreement for digital PCR instruments. As the prime contractor, Bio-Rad will provide services and support for digital PCR instruments located at the National Cancer Institute in Rockville, Maryland over a one year period from November 2023 through November 2024. The contract is a firm fixed...
- <p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480.00 on March 30, 2020, with performance completion by March 31, 2021. Work is performed in Bethesda, Maryland. This firm fixed-price purchase order acquired molecular diagnostics products or services—specific scope details are not provided in the award documentation.</p>
- The National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,880.00 firm fixed-price purchase order contract to Nexus Group, LLC, a small, minority-owned, and self-certified small disadvantaged business. This service agreement, which does not have a set-aside designation, will provide specialized equipment maintenance, repair, calibration, and support services to the NCI's facilities in Bethesda, Maryland through August 31, 2025....
- <p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for one QIAsymphony SP System valued at $93,067.38 on August 19, 2020. The instrument supports the National Cancer Institute's Cancer Center for Research Laboratory of Pathology at its Germantown, Maryland location. The order carries firm fixed pricing and ultimate completion was scheduled for September 20, 2020. No small business set-aside applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. on June 8, 2026, for maintenance services on Novocyte 3000 and NovoSampler Pro equipment, valued at $17,520.00, with a completion date of June 7, 2027. Work is performed in Bethesda, Maryland. The contract is firm fixed price with no set-aside designation.</p>
- <p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for system maintenance services valued at $152,280.00, effective July 19, 2026. The order covers a one-year period of performance through July 18, 2027 and carries a firm fixed-price structure with no small business set-aside. Work is performed in Bethesda, Maryland. The contract references quote HGO061126-01 and maintains an ultimate completion date of July 18, 2031.</p>
- <p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $20,283.34 on April 24, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland. The order is set to complete by July 19, 2020.</p>